Home/Pipeline/PWD for NPWT (Phase II Enhancement)

PWD for NPWT (Phase II Enhancement)

Incisional Wounds

Phase 2Active

Key Facts

Indication
Incisional Wounds
Phase
Phase 2
Status
Active
Company

About Applied Tissue Technologies

Applied Tissue Technologies is an innovation-driven wound care company focused on regenerative medicine and medical devices. Its flagship Platform Wound Device (PWD) represents a potential paradigm shift in negative pressure wound therapy by eliminating the need for a wound contact layer, enabling direct topical drug delivery, and simplifying deployment in austere environments. With strong foundational support from U.S. Department of Defense grants and a seasoned leadership team anchored by a renowned plastic surgeon, ATT is advancing its PWD through clinical studies while addressing both military and large-scale civilian wound care needs.

View full company profile